Patent
CRF And analogs
Wylie Vale,Joachim Spiess,Catherine Rivier,Jean Rivier +3 more
- 17 May 1982
21
TL;DR: A number of analogs have been synthesized that are at least as potent as CRF, and these analogs or pharmaceutically acceptable salts thereof can be administered to mammals to achieve a substantial elevation of ACTH, endorphin, β-lipotropin and corticosterone levels and/or a lowering of blood pressure over an extended period of time as mentioned in this paper.
read more
Abstract: CRF (Corticotropin Releasing Factor) has the formula: H-Ser-Gln-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Thr-Lys-Ala-Asp-Gln-Leu-Ala-Gln-Gln-Ala-His-Ser-Asn-Arg-Lys-Leu-Leu-Asp-Ile-Ala-NH2. Analogs have been synthesized that are at least as potent as CRF, and CRF or these analogs or pharmaceutically acceptable salts thereof, dispersed in a pharmaceutically acceptable liquid or solid carrier, can be administered to mammals to achieve a substantial elevation of ACTH, β-endorphin, β-lipotropin and corticosterone levels and/or a lowering of blood pressure over an extended period of time. In the analogs, one or more of the first three N-terminal residues may be deleted or may be substituted by a peptide up to 10 amino acids long and/or by an acylating agent containing up to 7 carbon atoms. Ala in the 41-position may also be substituted or deleted so long as the remaining C-terminus is amidated. Several other substitutions may also be made throughout the chain.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Patent
Compounds for control of appetite, blood pressure, cardiovascular response, libido, and circadian rhythm
Ambikaipakan Balasubramanium,William T. Chance +1 more
- 13 Sep 2005
TL;DR: In this article, the authors describe methods of treatment of mammals using such dipeptides and tripeptide analogs for control of appetite, blood pressure, cardiovascular response, libido, and circadian rhythm.
71
Patent
Anti-inflammatory peptide analogs and treatment to inhibit vascular leakage in injured tissues
Edward T. Wei
- 04 Aug 1993
TL;DR: The peptide analogs of the invention have the primary sequence TN-A1-A2-A3-A4-A5-A6-TC where one of the moieties is in the D-configuration.
35
Patent
Synthetic polypeptides corresponding to portions of proteinoids translated from brain-specific mRNAs, receptors, methods and diagnostics using the same
J. Gregor Sutcliffe
- 06 Jun 1995
TL;DR: Synthetic polypeptides whose sequences correspond substantially to amino acid residue sequences of at least portions of naturally occurring proteinoids translated from brain-specific mRNAs are disclosed as mentioned in this paper.
35
Patent
Method of inhibiting inflammatory response
Edward T. Wei,Juliann G. Kiang +1 more
- 03 Jul 1986
TL;DR: In this article, a method for inhibiting an inflammatory response in the skin or mucosal membranes of a patient is provided in which a therapeutically effective amount of a neuropeptide, such as Corticotropin Releasing Factor ("CRF") or its analogs, is administered.
34
Patent
Cloning and recombinant production of crf receptor(s)
Marilyn H. Perrin,Ruoping Chen,Kathy A. Lewis,Wylie Vale,Cynthia J. Donaldson,Paul E. Sawchenko +5 more
- 06 Dec 1995
TL;DR: In this paper, G-protein-coupled receptor proteins (CRF-R) are characterized by having sufficient binding affinity for corticotropin releasing factor such that concentrations of 10 nM of CRF occupy 50% of the binding sites of said receptor protein.
23
Related Papers (5)
[...]
Jean E. F. Rivier,Joachim Spiess,Wylie W. Vale +2 more
- 13 Apr 1984
Wylie Vale,Jean Rivier,Jeffrey Schwartz +2 more
- 11 Apr 1990
[...]
Jean E. F. Rivier,Wylie W. Vale,Spiess Joachim +2 more
- 04 Oct 1983
[...]
Jaroslav H. Boublik,Jean Rivier,Marvin R. Brown,Neal A. Scott +3 more
- 15 Jul 1988
Jean Rivier,Joachim Spiess,Wylie Vale +2 more
- 02 Oct 1985